Nexgel (NXGLW) Revenue (2018 - 2025)

Nexgel has reported Revenue for 8 years, with the latest figure at $2.8 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue fell 8.06% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $11.4 million (up 31.46% YoY), and the FY2025 full-year result was $11.4 million, up 31.46% from the prior year.
• Revenue for Q4 2025 stood at $2.8 million, down from $2.9 million in the prior quarter.
• The five-year high for Revenue was $3.0 million in Q4 2024, with the low at $267000.0 in Q1 2021.
• Historically, Revenue has averaged $1.4 million across 5 years, with a median of $1.1 million in 2023.
• Annual changes were most pronounced in 2021 — Revenue surged 427.72% — and 2025, when it retreated 8.06%.
• Nexgel's Revenue stood at $533000.0 in 2021, then declined by 1.69% to $524000.0 in 2022, then surged by 106.49% to $1.1 million in 2023, then soared by 181.05% to $3.0 million in 2024, then decreased by 8.06% to $2.8 million in 2025.
• The last three Revenue figures came in at $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.